Lisocabtagene Maraleucel for Treatment of Relapsed and Refractory Primary Mediastinal Large B‐cell Lymphoma in an Adolescent Patient
EJHaem(2024)
Key words
adolescent,AYA,lisocabtagene maraleucel,outcome,primary mediastinal large B-cell lymphoma,refractory,relapsed,safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined